‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
Luigi Luca Cavalli-Sforza dies at 96
Cavalli-Sforza helped create the field of genetic geography and was one of the founders of cultural evolution, a theory that social change resembles a Darwinian evolutionary process.
Magazine explores vision of Stanford Medicine
The summer issue of Stanford Medicine highlights research and programs that reflect a shared vision for the future of the School of Medicine, Stanford Health Care and Lucile Packard Children’s Hospital Stanford.
Same mutations fuel cancer metastases
The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.
Predicting aneurysm risk from DNA
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
Weather predicts incidence of snakebites
Rattlesnake bites, contrary to public opinion, increase after periods of high rainfall, not drought, according to a Stanford-led study that examined 20 years of snakebite history in California.
Safer gene therapy?
A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.
Toll of armed conflict in Africa
A Stanford-led analysis of the indirect impact of armed conflict in Africa shows that as many as 3.5 million infants born within 30 miles of combat were killed over two decades.
Ketamine tied to opioid system
Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.
John Farquhar dies at 91
John Farquhar, a beloved mentor, pioneer in cardiovascular disease prevention and professor emeritus of medicine and of health research and policy at Stanford, died Aug. 22 at the age of 91.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.